133 related articles for article (PubMed ID: 26964858)
81. Properties of Native High-Density Lipoproteins Inspire Synthesis of Actively Targeted
McMahon KM; Plebanek MP; Thaxton CS
Adv Funct Mater; 2016 Nov; 26(43):7824-7835. PubMed ID: 28717350
[TBL] [Abstract][Full Text] [Related]
82. Peptidomimetics Therapeutics for Retinal Disease.
Parsons DE; Lee SH; Sun YJ; Velez G; Bassuk AG; Smith M; Mahajan VB
Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33668179
[TBL] [Abstract][Full Text] [Related]
83. Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain.
Rungta RL; Choi HB; Lin PJ; Ko RW; Ashby D; Nair J; Manoharan M; Cullis PR; Macvicar BA
Mol Ther Nucleic Acids; 2013 Dec; 2(12):e136. PubMed ID: 24301867
[TBL] [Abstract][Full Text] [Related]
84. Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.
Hruby VJ; Cai M
Annu Rev Pharmacol Toxicol; 2013; 53():557-80. PubMed ID: 23294313
[TBL] [Abstract][Full Text] [Related]
85. Unusual Amino Acids in Medicinal Chemistry.
Blaskovich MA
J Med Chem; 2016 Dec; 59(24):10807-10836. PubMed ID: 27589349
[TBL] [Abstract][Full Text] [Related]
86. Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia.
Hu B; Li B; Li K; Liu Y; Li C; Zheng L; Zhang M; Yang T; Guo S; Dong X; Zhang T; Liu Q; Hussain A; Weng Y; Peng L; Zhao Y; Liang XJ; Huang Y
Sci Adv; 2022 Feb; 8(7):eabm1418. PubMed ID: 35171673
[TBL] [Abstract][Full Text] [Related]
87. Toxicity profiling of several common RNAi-based nanomedicines: a comparative study.
Landesman-Milo D; Peer D
Drug Deliv Transl Res; 2014 Feb; 4(1):96-103. PubMed ID: 25786620
[TBL] [Abstract][Full Text] [Related]
88. 25 years of maturation: A systematic review of RNAi in the clinic.
Corydon IJ; Fabian-Jessing BK; Jakobsen TS; Jørgensen AC; Jensen EG; Askou AL; Aagaard L; Corydon TJ
Mol Ther Nucleic Acids; 2023 Sep; 33():469-482. PubMed ID: 37583575
[TBL] [Abstract][Full Text] [Related]
89. Identification of Potent siRNA Delivery Peptides Using Computer Modeling.
Men K; Liu M; Zhang X; Yang Y; Zhang R; Wang Y; Hu D; Zhou B; Yang L
Adv Sci (Weinh); 2024 Apr; 11(14):e2308345. PubMed ID: 38311577
[TBL] [Abstract][Full Text] [Related]
90. Intratracheal Administration of siRNA Triggers mRNA Silencing in the Lung to Modulate T Cell Immune Response and Lung Inflammation.
Ng B; Cash-Mason T; Wang Y; Seitzer J; Burchard J; Brown D; Dudkin V; Davide J; Jadhav V; Sepp-Lorenzino L; Cejas PJ
Mol Ther Nucleic Acids; 2019 Jun; 16():194-205. PubMed ID: 30901578
[TBL] [Abstract][Full Text] [Related]
91. Branched RNA: A New Architecture for RNA Interference.
Aviñó A; Ocampo SM; Perales JC; Eritja R
J Nucleic Acids; 2011 Mar; 2011():586935. PubMed ID: 21461398
[TBL] [Abstract][Full Text] [Related]
92. SPLUNC1 α6 Peptidomimetic: A Novel Therapeutic for Asthma.
Vlahos R
Am J Respir Cell Mol Biol; 2022 Mar; 66(3):241-242. PubMed ID: 34905718
[No Abstract] [Full Text] [Related]
93. Heterocycles in peptidomimetics and pseudopeptides: design and synthesis.
Cerminara I; Chiummiento L; Funicello M; Guarnaccio A; Lupattelli P
Pharmaceuticals (Basel); 2012 Mar; 5(3):297-316. PubMed ID: 24281380
[TBL] [Abstract][Full Text] [Related]
94. Photocontrolled Intracellular RNA Delivery Using Nanoparticles or Carrier-Photosensitizer Conjugates.
Watanabe K; Ohtsuki T
Prog Mol Biol Transl Sci; 2016; 139():101-19. PubMed ID: 26970192
[TBL] [Abstract][Full Text] [Related]
95. Elucidation of the physicochemical properties and potency of siRNA-loaded small-sized lipid nanoparticles for siRNA delivery.
Sato Y; Note Y; Maeki M; Kaji N; Baba Y; Tokeshi M; Harashima H
J Control Release; 2016 May; 229():48-57. PubMed ID: 26995758
[TBL] [Abstract][Full Text] [Related]
96. Hydroxychloroquine-conjugated gold nanoparticles for improved siRNA activity.
Perche F; Yi Y; Hespel L; Mi P; Dirisala A; Cabral H; Miyata K; Kataoka K
Biomaterials; 2016 Jun; 90():62-71. PubMed ID: 26986857
[TBL] [Abstract][Full Text] [Related]
97. Efficient Gene Knockdown in Mouse Oocytes through Peptide Nanoparticle-Mediated SiRNA Transfection.
Jin Z; Li R; Zhou C; Shi L; Zhang X; Yang Z; Zhang D
PLoS One; 2016; 11(3):e0150462. PubMed ID: 26974323
[TBL] [Abstract][Full Text] [Related]
98. Astrocyte-targeted siRNA delivery by adenosine-functionalized LNP in mouse TBI model.
Xiao H; Amarsaikhan O; Zhao Y; Yu X; Hu X; Han S; Chaolumen ; Baigude H
Mol Ther Nucleic Acids; 2023 Dec; 34():102065. PubMed ID: 38028196
[TBL] [Abstract][Full Text] [Related]
99. Oral Delivery of SARS-CoV-2 DNA Vaccines Using Attenuated
Zhu D; Mengyue M; Qimuge A; Bilige B; Baiyin T; Temuqile T; Chen S; Borjigen S; Baigude H; Yang D
Mol Gen Microbiol Virol; 2022; 37(3):159-166. PubMed ID: 36589521
[TBL] [Abstract][Full Text] [Related]
100. Effect of the array of amines on the transfection efficiency of cationic peptidomimetic lipid molecules into neural cells.
Yu X; Xiao H; Muqier M; Han S; Baigude H
RSC Adv; 2022 Jul; 12(33):21567-21573. PubMed ID: 35975061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
